Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Ospedale Regina Elena

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Ospedale Regina Elena is a prominent public healthcare facility and center of excellence for oncological research and care. Formally known as the Istituto Nazionale Tumori Regina Elena (IRE), it operates under the umbrella of the Istituti Fisioterapici Ospitalieri (IFO) alongside the San Gallicano Dermatological Institute. Founded in 1933 and recognized since 1939 as an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), the hospital tightly integrates advanced biomolecular diagnostics, high-volume precision oncology surgeries (including extensive robotic procedures), and experimental translational therapies.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
39Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
23Active Trials
Source: Trial-derived.
12Completed Trials
Source: Trial-derived.
55Unique Conditions
Source: Trial-derived.
59Unique Sponsors

Conditions

Source: Trial-derived. Non Small Cell Lung Cancer (3)Source: Trial-derived. Adult Solid Tumor (2)Source: Trial-derived. Breast Neoplasms (2)Source: Trial-derived. Metastatic Non-Squamous Non-Small Cell Lung Cancer (2)Source: Trial-derived. Non-small Cell Lung Cancer (2)Source: Trial-derived. Ovarian Cancer (2)Source: Trial-derived. Triple Negative Breast Neoplasms (2)Source: Trial-derived. Advanced BRAFV600 Wild-type Melanoma (1)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (5)Source: Trial-derived. Regina Elena Cancer Institute (5)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology (2)Source: Trial-derived. AstraZeneca (2)Source: Trial-derived. CatalYm GmbH (2)Source: Trial-derived. Daiichi Sankyo (2)Source: Trial-derived. EMD Serono Research & Development Institute, Inc. (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Histology / pathology

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. General anaesthesia
Source: AI-inferred. Implantable ultrasound blood-brain barrier opening
Source: AI-inferred. Invasive arterial blood pressure monitoring
Source: AI-inferred. PD-L1 tumour expression testing
Source: AI-inferred. Radiographic tumour response assessment
Source: AI-inferred. Serial radiological tumour imaging
Source: AI-inferred. Tumour EGFR mutation testing